Second Sight Medical Products Inc
EYESW · NASDAQ
12/31/2024 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $18 | $70 | $3 | $11 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $1 |
| Other Curr. Assets | $2 | $1 | $1 | $0 |
| Total Curr. Assets | $20 | $71 | $4 | $13 |
| Property Plant & Equip (Net) | $20 | $0 | $0 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $0 | $0 | $0 |
| Total NC Assets | $21 | $0 | $0 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $42 | $71 | $4 | $17 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $0 | $1 |
| Short-Term Debt | $1 | $0 | $2 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4 | $2 | $2 | $6 |
| Total Curr. Liab. | $6 | $2 | $5 | $7 |
| LT Debt | $18 | $0 | $0 | $2 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $18 | $0 | $0 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $24 | $3 | $5 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $320 | $0 |
| Common Stock | $0 | $348 | $270 | $264 |
| Retained Earnings | -$122 | -$329 | -$320 | -$305 |
| AOCI | $0 | -$0 | -$0 | -$1 |
| Other Equity | $140 | $49 | -$270 | $49 |
| Total Equity | $18 | $68 | -$1 | $7 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $42 | $71 | $4 | $17 |
| Net Debt | $1 | -$69 | -$1 | -$9 |